| Assessment Status | Rapid review complete |
| HTA ID | - |
| Drug | Degarelin |
| Brand | Firmagon® |
| Indication | For the treatment of prostate cancer |
| Assessment Process | |
| Rapid review completed | 15/10/2019 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation Not Recommended |
Cost-effectiveness of Degarelix (Firmagon®)